[APLS] QoQ Quarter Result on 31-Mar-2018 [#Q1]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
30-Apr-2018
Financial Year
2018
Quarter
31-Mar-2018 [#Q1]
Profit Trend
QoQ- -19.06%
YoY- -140.15%
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Quarter Result
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Revenue 12 0 0 0 12 0 0 -
PBT -36,459 -35,972 -33,334 -21,736 -18,256 -11,573 -12,126 107.89%
Tax 2,383 -281 -33,669 267 -17,896 -11,589 -12,138 -
NP -36,459 -35,972 -33,334 -21,736 -18,256 -11,573 -12,126 107.89%
Tax Rate - - - - - - - -
Total Cost 36,471 35,972 33,334 21,736 18,267 11,573 12,126 107.94%
Ratio Analysis
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
NP Margin -315,885.24 0.00 0.00 0.00 -158,169.26 0.00 0.00 -
Per Share
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
EPS -0.65 -0.64 -0.61 -0.43 -0.36 -0.30 -0.67 -1.99%
EPS Diluted -0.63 -0.64 -0.61 -0.43 -0.36 -0.30 -0.67 -4.01%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.